Showing results (211-220 of 445) with videos related to

Sort By:
Pageof 45
Nutrients|October 1, 2016
The VITAH Trial-Vitamin D Supplementation and Cardiac Autonomic Tone in Patients with End-Stage Kidney Disease on Hemodialysis: A Blinded, Randomized Controlled TrialMichelle C Mann, Derek V Exner, Brenda R Hemmelgarn, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 26, 2026
A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental GlomerulosclerosisHiddo J L Heerspink, Dustin J Little, Samvel B Gasparyan, et al.
Kidney International|July 27, 2026
New insights from DAPA-CKD indicate dapagliflozin modulates key pathways related to kidney outcomesMark André de la Rambelje, Niels Jongs, Peter J Greasley, et al.
Advances in Therapy|April 18, 2023
The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical TrialBartholomeus J A Willigers, Mario Ouwens, Andrew Briggs, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2024
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic AcidosisNavdeep Tangri, Vandana S Mathur, David A Bushinsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 24, 2021
Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney DiseaseJulie H Ishida, Cynthia Chauhan, Barbara Gillespie, et al.
BMJ Open|July 16, 2025
Patient-reported outcome measures for fatigue in patients with chronic kidney disease: a systematic reviewAnastasia Hughes, Angela Ju, Rosanna Cazzolli, et al.
Clinical Kidney Journal|February 5, 2024
Potentially modifiable factors associated with health-related quality of life among people with chronic kidney disease: baseline findings from the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohortThomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, et al.
Glomerular Diseases|August 15, 2024
Effects of Dapagliflozin in Patients with Membranous NephropathyGlenn M Chertow, Hiddo Lambers Heerspink, Patrick B Mark, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2020
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS ProgramBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
Pageof 45